Exderm NM Cream
By Exderm NM
Rx
15gm Cream in a Tube

Composition
Clobetasol(0.05% w/w) + Miconazole(2% w/w) + Neomycin(0.5% w/w)

Manufacturer - Omni Lifesciences Pvt Ltd
201 ELEGANCE PRODUCTIVITYROAD VADODARA GJ 390020 IN

Expires on or after
January, 2027

liver
No interaction or concerns have been found or established regarding the impact of Exderm NM Cream on the liver. It is always recommended to use caution when using any medication or cream, especially if you have existing liver issues. However, based on the available information, there are no known specific warnings or precautions related to liver safety when using Exderm NM Cream. It is advisable to follow the usage instructions provided and consult with your healthcare provider if you have any concerns or experience any unusual symptoms while using this cream.

kidney
No interaction between Exderm NM Cream and kidneys has been found. Consult with your doctor for proper guidance before using Exderm NM Cream.

alcohol
No interaction has been found or established between alcohol and Exderm NM Cream. It is always important to consider safety during pregnancy.

driving
Using Exderm NM Cream has not been shown to interact with driving abilities. It is important to always be cautious when driving, especially if you experience any side effects that may affect your focus or reaction time.

pregnancy
Exderm NM Cream may not be safe to use during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will assess the risks and benefits before recommending this cream. It is essential to consult your doctor regarding its use during pregnancy.

breastfeeding
Exderm NM Cream is considered safe for use during breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | DERMA |
Action Class | - |
₹59
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024